Tatyana I Metelitsina1, Darrel J Waggoner, Michael A Grassi. 1. *Retina Consultants, Ltd., Des Plaines, Illinois; †Department of Human Genetics and Pediatrics, University of Chicago, Chicago, Illinois; and ‡Retina Chemical Genomics Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois. Metelitsina is now at Eye Care Specialists, LLC, Cape Girardeau, Missouri.
Abstract
PURPOSE: To report a case of Batten disease due to a previously unreported mutation in PPT1. METHODS: A 9-year-old girl presented with classic clinical findings of Batten Disease. RESULTS: Genetic testing for the mutations in the most common Batten disease gene, CLN3, was negative. Evaluation of a panel of genes known to be implicated in neuronal ceroid lipofuscinoses revealed disease causing mutations in PPT1, one of which was novel. CONCLUSION: Mutations in PPT1 typically cause the infantile form of neuronal ceroid lipofuscinosis. Clinical diagnosis of the juvenile form of neuronal ceroid lipofuscinosis, Batten disease, should still be considered in cases with negative CLN3 genetic testing. Batten disease can occur due to genetic heterogeneity. Testing of other members of the neuronal ceroid lipofuscinosis gene family can lead to confirmation of the correct diagnosis.
PURPOSE: To report a case of Batten disease due to a previously unreported mutation in PPT1. METHODS: A 9-year-old girl presented with classic clinical findings of Batten Disease. RESULTS: Genetic testing for the mutations in the most common Batten disease gene, CLN3, was negative. Evaluation of a panel of genes known to be implicated in neuronal ceroid lipofuscinoses revealed disease causing mutations in PPT1, one of which was novel. CONCLUSION: Mutations in PPT1 typically cause the infantile form of neuronal ceroid lipofuscinosis. Clinical diagnosis of the juvenile form of neuronal ceroid lipofuscinosis, Batten disease, should still be considered in cases with negative CLN3 genetic testing. Batten disease can occur due to genetic heterogeneity. Testing of other members of the neuronal ceroid lipofuscinosis gene family can lead to confirmation of the correct diagnosis.
Authors: Jonathan W Mink; Erika F Augustine; Heather R Adams; Frederick J Marshall; Jennifer M Kwon Journal: J Child Neurol Date: 2013-07-09 Impact factor: 1.987
Authors: H M Mitchison; S L Hofmann; C H Becerra; P B Munroe; B D Lake; Y J Crow; J B Stephenson; R E Williams; I L Hofman; P E Taschner; J J Martin; M Philippart; E Andermann; F Andermann; S E Mole; R M Gardiner; A M O'Rawe Journal: Hum Mol Genet Date: 1998-02 Impact factor: 6.150
Authors: Maria Kousi; Eija Siintola; Lenka Dvorakova; Hana Vlaskova; Julie Turnbull; Meral Topcu; Deniz Yuksel; Sarenur Gokben; Berge A Minassian; Milan Elleder; Sara E Mole; Anna-Elina Lehesjoki Journal: Brain Date: 2009-02-05 Impact factor: 15.255
Authors: Sonia Brun; Eloïne Bestion; Eric Raymond; Firas Bassissi; Zuzana Macek Jilkova; Soraya Mezouar; Madani Rachid; Marie Novello; Jennifer Tracz; Ahmed Hamaï; Gilles Lalmanach; Lise Vanderlynden; Raphael Legouffe; Jonathan Stauber; Thomas Schubert; Maximilian G Plach; Jérôme Courcambeck; Cyrille Drouot; Guillaume Jacquemot; Cindy Serdjebi; Gael Roth; Jean-Pierre Baudoin; Christelle Ansaldi; Thomas Decaens; Philippe Halfon Journal: Autophagy Date: 2021-11-05 Impact factor: 13.391